By: Ulka Campbell, Head of Scientific Strategy, Aetion Of the many potential use cases for real-world data (RWD) and real-world evidence (RWE), one of the most important is improving the information available about how medical products work in populations that have been historically underrepresented in clinical trials. Striving [...]
This episode of tHEORetically Speaking features real-world evidence experts Alexandrina Balanean, Parisa Asgarisabet, and Danielle Gentile from Cardinal Health discussing the problems caused by lack of diverse representation in clinical trials.
Moving beyond static evidence development to ensure local market access success; responding to recent changes in governmental drug regulations and the role of automation Written by Grammati Sarri and Radek Wasiak The worldwide drug regulation landscape is rapidly changing. The introduction of the EU health technology assessment (HTA) Regulation [...]
Despite laws to eliminate sex-based wage disparity, women continue to experience pay inequality across all industries, prominently in healthcare. Women, making up two-thirds of the global healthcare workforce, were paid an average of 82% of what men earned in 2022. The gender pay gap is more [...]
The pharmaceutical industry is in a frenzy over the recently released list of the drugs subject to price negotiation under the Inflation Reduction Act of 2023 (IRA) and the Act’s potential impact on profits. But an even bigger force has been slowly transforming Medicare in a way [...]
Today's episode of tHEORetically speaking features Gary Curhan, Chief Medical Officer and Jessica Paulus, Vice President of Research at OM1, as they answer questions on Leveraging Real-World Data for Precision Obesity Treatment.
Supplier Spotlight® highlights the unique skills and services offered by organizations that are part of our CONNECTED COMMUNITY™. Recently, we spoke with LexisNexis Risk Solutions which supports the biopharma industry by offering scientific data solutions and consultancy centered around regulatory expertise. Check out the interview below and visit LexisNexis Risk Solutions. What is [...]
In this interview with Chad Rose, General Manager of hēRo3, he explains how biopharma is incorporating critical HEOR insights into decision-making for early pipeline assets. Why is there a need to revolutionize the way HEOR insights are used in the decision-making process? Now more than ever, there [...]
The ever-expanding field of pharmacovigilance highlights the importance of identifying and tackling problems with real-world safety reporting. Despite this drive to improve healthcare, overtaxed healthcare providers face a current real-world safety reporting process that is too burdensome. For example, researchers reviewed 29 studies and identified four priorities to [...]
Barely a day goes by without a headline touting how some new generative AI system will transform our lives by detecting cancer, expediting diagnosis, or helping doctors provide better care. But I’d bet my house that none of these claims will turn out to be true. ChatGPT, Google [...]
This podcast segment features the Q&A from Magnolia Market Access’ April 6, 2023 webinar with HealthEconomics.Com. In this episode of tHEORetically speaking, join Dr. Pamela Landsman-Blumberg from Magnolia Market Access and Dr. Rick Chapman from Innovation and Value Initiatives as they answer questions on the importance of social determinants [...]
Precision medicine and value-based care are buzzwords used over the last two decades. At inception, these principles were seen as two opposing forces in the fight against cancer. Now, industry leaders view precision medicine and value-based care as two sides of the same coin. Data demonstrating the impact [...]
This podcast segment features the Q&A from DistillerSR’s March 15, 2023 webinar with HealthEconomics.Com. Join Gillian Sibbring, Sue O’Leary, Ben Rousseau, Patti Peeples, and Rachel Forrest as they answer questions on systematic literature review issues that can negatively affect your Global Value Dossiers (GVDs) and how automation can improve [...]
This podcast segment features the Q&A from Cardinal Health's March 23, 2023 webinar with HealthEconomics.Com. Join Dr. Bruce Feinberg, Dr. Danielle Gentile, Dr. Parisa Asgarisabet, and Alexandrina Balanean from Cardinal Health as they answer questions on the economic impact and role of real world evidence (RWE) in improving representativeness of [...]
The current healthcare environment reshapes the three key factors in market access – value, evidence, and commercial positioning of new treatments. Greater emphasis on patient centricity meets budget cuts. Leading to a sharper focus on demonstrating patient benefit value specific to the treatment situation. At the same time, the [...]